Edward Savory,Michael Higginbottom,Kathryn Oliver,Viet-Anh Anne Horgan
申请号：
US15335751
公开号：
US09890160B2
申请日:
2016.10.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to compounds of formula (I),and their pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomers or N-oxides, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.
